| Primary |
| Dementia Alzheimer's Type |
50.0% |
| Hyperparathyroidism Secondary |
50.0% |
|
| Electrocardiogram Qt Interval Abnormal |
50.0% |
| Proteinuria |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.6% |
| Drug Use For Unknown Indication |
14.7% |
| Hypertension |
9.1% |
| Prophylaxis |
6.9% |
| Osteoporosis |
6.7% |
| Multiple Myeloma |
5.8% |
| Rheumatoid Arthritis |
4.9% |
| Hypoparathyroidism |
3.7% |
| Diuretic Therapy |
3.4% |
| Juvenile Arthritis |
2.2% |
| Gastritis |
1.9% |
| Hyperparathyroidism Secondary |
1.7% |
| Behcet's Syndrome |
1.3% |
| Anaemia |
1.1% |
| Cardiac Failure Chronic |
1.1% |
| Congestive Cardiomyopathy |
1.1% |
| Osteoporosis Prophylaxis |
1.1% |
| Prophylaxis Urinary Tract Infection |
1.1% |
| Constipation |
0.7% |
| Femur Fracture |
0.7% |
|
| Dehydration |
12.2% |
| Visual Acuity Reduced |
12.2% |
| Liver Disorder |
10.8% |
| Renal Failure |
9.5% |
| Rash Papular |
6.8% |
| Follicular Mucinosis |
4.1% |
| Hydronephrosis |
4.1% |
| Hypercalcaemia |
4.1% |
| Milk-alkali Syndrome |
4.1% |
| Optic Disc Disorder |
4.1% |
| Prothrombin Time Abnormal |
4.1% |
| Calciphylaxis |
2.7% |
| Colitis Collagenous |
2.7% |
| Convulsion |
2.7% |
| Diarrhoea |
2.7% |
| Electrocardiogram Qt Prolonged |
2.7% |
| Hypokalaemia |
2.7% |
| Intracranial Pressure Increased |
2.7% |
| Premature Delivery |
2.7% |
| Rhabdomyolysis |
2.7% |
|
| Concomitant |
| Rheumatoid Arthritis |
22.3% |
| Product Used For Unknown Indication |
22.2% |
| Drug Use For Unknown Indication |
15.1% |
| Osteoporosis |
7.3% |
| Hypertension |
6.9% |
| Prophylaxis |
6.9% |
| Diabetes Mellitus |
1.7% |
| Hyperparathyroidism Secondary |
1.6% |
| Osteoporosis Prophylaxis |
1.6% |
| Renal Failure |
1.5% |
| Gastritis Prophylaxis |
1.5% |
| Antibiotic Prophylaxis |
1.5% |
| Insomnia |
1.4% |
| Renal Transplant |
1.4% |
| Adverse Drug Reaction |
1.3% |
| Constipation |
1.3% |
| Gastritis |
1.2% |
| Renal Failure Chronic |
1.2% |
| Crohn's Disease |
1.1% |
| Anaemia |
1.1% |
|
| Vomiting |
11.7% |
| Rhabdomyolysis |
9.9% |
| Pyrexia |
9.7% |
| Urinary Tract Infection |
6.1% |
| Death |
5.3% |
| Pneumonia |
5.3% |
| Renal Failure |
5.3% |
| Renal Failure Acute |
5.3% |
| Therapeutic Response Decreased |
5.0% |
| Tremor |
4.0% |
| Hypocalcaemia |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Tetany |
3.6% |
| Proteinuria |
3.4% |
| Renal Failure Chronic |
3.2% |
| Renal Impairment |
3.2% |
| Rheumatoid Arthritis |
3.2% |
| Peritonitis |
3.0% |
| Urticaria |
3.0% |
| Hypoglycaemia |
2.8% |
|
| Interacting |
| Hypertension |
53.8% |
| Drug Use For Unknown Indication |
23.1% |
| Product Used For Unknown Indication |
15.4% |
| Cerebral Infarction |
7.7% |
|
| Hyperkalaemia |
40.0% |
| Dehydration |
20.0% |
| Hepatocellular Damage |
20.0% |
| Hypercalcaemia |
20.0% |
|
